Roivant reported a Phase 2 failure on Tuesday for a program analysts expected would not succeed.
The compound in question, namilumab, was being tested in …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A groundbreaking study has shed new light on the astonishing diversity of protein structures and their folds in nature.
Related Articles Colorado’s first legal cannabis party bus is preparing to roll up and roll out on the streets of Denver this week, offering shuttle
Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.